Targeted therapies for renal cell carcinoma.
- Published in:
- Targeted Oncology, 2007, v. 2, n. 1, p. 7, doi. 10.1007/s11523-006-0041-2
- By:
- Publication type:
- Article
Works matching IS 17762596 AND DT 2007 AND VI 2 AND IP 1
Results: 7
1
2
Targeted therapies in T-cell malignancies.
- Published in:
- Targeted Oncology, 2007, v. 2, n. 1, p. 39, doi. 10.1007/s11523-006-0035-0
- By:
- Publication type:
- Article
3
Lymph node metastasis as a new target for cancer treatment.
- Published in:
- Targeted Oncology, 2007, v. 2, n. 1, p. 49, doi. 10.1007/s11523-006-0037-y
- By:
- Publication type:
- Article
4
Mechanisms of resistance to EGFR inhibitors.
- Published in:
- Targeted Oncology, 2007, v. 2, n. 1, p. 31, doi. 10.1007/s11523-006-0038-x
- By:
- Publication type:
- Article
5
Renewed hope in the treatment of renal cell carcinoma.
- Published in:
- 2007
- By:
- Publication type:
- Editorial
6
New multitargeted treatments with antiangiogenic and antitumor activity: focus on sunitinib.
- Published in:
- Targeted Oncology, 2007, v. 2, n. 1, p. 17, doi. 10.1007/s11523-006-0040-3
- By:
- Publication type:
- Article
7
Somatic von Hippel-Lindau ( VHL) gene analysis and clinical outcome under antiangiogenic treatment in metastatic renal cell carcinoma: preliminary results.
- Published in:
- Targeted Oncology, 2007, v. 2, n. 1, p. 3, doi. 10.1007/s11523-006-0039-9
- By:
- Publication type:
- Article